Mobia Medical targets broader Vivistim adoption as CMS proposes keeping outpatient payment near $45,000 in 2027

PUBT · 1d ago
Mobia Medical targets broader Vivistim adoption as CMS proposes keeping outpatient payment near $45,000 in 2027
- Mobia Medical plans to expand hospital Vivistim programs in 2027, supported by CMS’s proposed continuation of New Technology APC 1580 reimbursement.
- The proposal keeps CPT code 64568 at about USD 45,000 per outpatient hospital case, preserving expected economics for broader adoption.
- Focus shifts to accelerating market uptake by widening access for Medicare beneficiaries as hospitals scale procedure capacity.
- The final CMS OPPS rule is expected in November, with any changes set to take effect Jan. 1, 2027.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mobia Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607021635PRIMZONEFULLFEED9756466) on July 02, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.